Assessing a drug's cost-benefits.
Raleigh
F
F
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D018967:Risperidone / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D006220:Haloperidol; D018967:Risperidone